For more than a decade, the Sabin PDP collaborated with partners from across the globe to develop new, low-cost vaccines that have little commercial market for diseases that primarily impact the world's poorest populations, including human hookworm, schistosomiasis, onchocerciasis, SARS and Chagas disease. Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development continue this research as of May 2017.
Research & Development
The Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin leverages the expertise of partners in the academic, public and private sectors, and promotes open-source research.
The 2017 Sabin Gold Medal Award honored Dr. Jan Holmgren for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery of the world's first effective oral cholera vaccine.
While rarely talked about, Neglected Tropical Diseases are the most widespread ailment among the world's poorest of the poor – yet also ironically the most prevalent in top global economies, experts say.
Neglected Tropical Diseases (NTDs) are “the most important diseases you've never heard of. These are the most common afflictions of the world's poor,” Peter Hotez, MD, PhD, told CNA Nov. 11.